Gildan Activewear Inc. (GIL)
Official siteCONSUMER CYCLICAL • APPAREL MANUFACTURING • NYSE
Market Cap: $6.42B
Last updated: Nov 17, 2026 at 11:06 AM ET
Gildan Activewear Inc. (GIL) Stock Forecast
Analysts expect Gildan Activewear (GIL) to earn $3.91 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.55B. Of 12 analysts, 11 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 5 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 12 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 92% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 5 | 41.7% |
| Buy | 6 | 50.0% |
| Hold | 1 | 8.3% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 12
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 9.7% and revenue estimates rise 0.4%.
- Fiscal year ending Dec 31, 2026
- $3.91
- EPS consensus, revenue $5.55B
- Fiscal year ending Dec 31, 2027
- $4.29
- EPS consensus, revenue $5.57B
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $3.91 | $3.70 to $4.73 | 12 | $5.55B | $5.41B to $6.05B | 12 |
| Dec 31, 2027 | $4.29 | $3.25 to $5.51 | 12 | $5.57B | $5.16B to $6.38B | 12 |
Quarterly Estimates
The EPS consensus rises from $0.51 for the quarter ending Dec 31, 2026 to $0.60 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.51 | $0.45 to $0.58 | 8 | $1.32B | $1.18B to $1.68B | 7 |
| Mar 31, 2027 | $0.60 | $0.54 to $0.69 | 3 | $1.17B | $1.17B to $1.17B | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 13 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 5 |
| Fiscal year ending Dec 31, 2027 | 1 | 7 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 16.3% from $4.67.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $3.91 | $4.60 | $4.63 | $4.67 | $4.67 | -16.3% |
| Fiscal year ending Dec 31, 2027 | $4.29 | $5.29 | $5.44 | $5.53 | $5.52 | -22.3% |
| Quarter ending Mar 31, 2027 | $0.60 | $0.70 | $0.75 | $0.73 | $0.73 | -18.0% |
Frequently Asked Questions About GIL
What is the GIL stock forecast?
Consensus analyst estimates put Gildan Activewear's EPS at $3.91 for the fiscal year ending Dec 31, 2026, on revenue of $5.55B. The consensus rating from 12 analysts is Buy.
How do analysts rate GIL stock?
Of 12 analysts covering Gildan Activewear, 5 rate it Strong Buy, 6 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from GIL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $3.91, with estimates from $3.70 to $4.73 from 12 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.29, with estimates from $3.25 to $5.51 from 12 analysts.
What revenue do analysts expect from Gildan Activewear next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.55B, with estimates from $5.41B to $6.05B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $5.57B, with estimates from $5.16B to $6.38B.
How many analysts cover GIL?
12 analysts rate Gildan Activewear stock, and 12 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
GIL pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors